000			01490 a2200409 4500
005			20250517130909.0
264		0	_c20181211
008			201812s 0 0 eng d
022			_a1473-1150
024	7		_a10.1038/tpj.2016.88 _2doi
040			_aNLM _beng _cNLM
100	1		_aMaldonado-Montoro, M
245	0	0	_aInfluence of IL6R gene polymorphisms in the effectiveness to treatment with tocilizumab in rheumatoid arthritis. _h[electronic resource]
260			_bThe pharmacogenomics journal _c01 2018
300			_a167-172 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAntibodies, Monoclonal, Humanized _xtherapeutic use
650	0	4	_aAntirheumatic Agents _xtherapeutic use
650	0	4	_aArthritis, Rheumatoid _xdrug therapy
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aOdds Ratio
650	0	4	_aPolymorphism, Single Nucleotide _xgenetics
650	0	4	_aReceptors, Interleukin-6 _xgenetics
650	0	4	_aRemission Induction _xmethods
650	0	4	_aRetrospective Studies
650	0	4	_aSeverity of Illness Index
650	0	4	_aTreatment Outcome
700	1		_aCañadas-Garre, M
700	1		_aGonzález-Utrilla, A
700	1		_aÁngel Calleja-Hernández, M
773	0		_tThe pharmacogenomics journal _gvol. 18 _gno. 1 _gp. 167-172
856	4	0	_uhttps://doi.org/10.1038/tpj.2016.88 _zAvailable from publisher's website
999			_c26691933 _d26691933